Koyfin Home > Directory > Health Care > Acceleron Pharma > Altman Z-score

Acceleron Pharma Altman Z-score Chart (XLRN)

Acceleron Pharma annual/quarterly Altman Z-score from 2012 to 2020.
  • Acceleron Pharma Altman Z-score for the quarter ending June 06, 2020 was 52.33 a 56.18% increase of 29.40 year over year
  • Acceleron Pharma Altman Z-score for the last 12 months ending June 06, 2020 was 34.19 a 33.23% increase of 11.36 year over year
  • Acceleron Pharma Annual Altman Z-score for 2019 was 22.93 a -121.95% decrease of -27.96 from 2018
  • Acceleron Pharma Annual Altman Z-score for 2018 was 50.89 a 39.72% increase of 20.21 from 2017
  • Acceleron Pharma Annual Altman Z-score for 2017 was 30.67 a 2.44% increase of 0.75 from 2016
Other Balance Sheet Metrics:
  • Acceleron Pharma Total Assets for the quarter ending September 09, 2018 was $338m a -15.10% decrease of -51m year over year
  • Acceleron Pharma Other Liabilities for the quarter ending December 12, 2018 was $4m a 14.46% increase of 1m year over year
  • Acceleron Pharma Total Equity for the quarter ending September 09, 2018 was $319m a -14.45% decrease of -46m year over year
View Chart On Koyfin

Quarterly XLRN Altman Z-score Data

06/202052.33
03/202046.59
12/201924.81
09/201922.93
06/201924.58
03/201925.23
12/201857.67
09/201868.91
06/201852.03
03/201869.19

Annual XLRN Altman Z-score Data

201922.93
201850.89
201730.67
201629.93
201514.91
201420.56
20135.43
2012-9.78
2011-0.88